Skip to main content

How do I…put patient safety first?

Patient safety is at the heart of everything we do. Join Scott behind the scenes as he shows us some of the steps taken to put patient safety first at our manufacturing sites.

Teva’s medicines treat nearly 200 million people around the world every day. We know that behind every patient there is a story, a family and a struggle. These challenges inspire us to find solutions to the medical problems people face.


Please note, this video was created before the COVID19 pandemic.


Teva’s portfolio of products is among the largest of any pharmaceutical company in the world - we deliver more than 2,400 different products to patients in more than 60 countries.

Our uncompromising commitment to quality and compliance begins with research and development. And it covers each stage of the drug development and commercialization process, from the procurement of raw materials, to the approval of our product submissions by regulatory authorities around the world and commercial distribution.

More than 20,000 colleagues support our global manufacturing network of 65 sites in 33 countries. Our quality and compliance professionals are a key part of the manufacturing process. They play a crucial role in meeting our quality commitments to patients and to the regulatory agencies that approve our medicines.


Find out more

  • Watch Hikmat, Paul and Amy as they go behind the scenes and show how their manufacturing site produces 480 million doses of medicine each year.

  • Discover how Teva is applying expertise, innovation and technology to improve health.

  • We’re hiring! Are you interested in what Scott does, or want to know about other roles at Teva? If so, check out our latest vacancies. 

You might also be interested

Rise of the Superbugs: 5 Key Questions Answered

Rise of the Superbugs: 5 Key Questions Answered

COVID-19 puts medicine supply security in Europe's spotlight

COVID-19 puts medicine supply security in Europe's spotlight

‘Biosimilars are advancing more treatment options for patients’

‘Biosimilars are advancing more treatment options for patients’

‘Half the world’s people lack access to medicines’

‘Half the world’s people lack access to medicines’

‘I’ve seen the impact that asthma and COPD can have’

‘I’ve seen the impact that asthma and COPD can have’

‘Patients who relied on their medicine before COVID19 rely on them just as much today.’

‘Patients who relied on their medicine before COVID19 rely on them just as much today.’

Helping Healthcare Services Resume

Helping Healthcare Services Resume

Renewing hope in healthcare's most powerful tool

Renewing hope in healthcare's most powerful tool